Georgetown University: Lung Neoplasms trials

The registry lists 12 Lung Neoplasms studies with Georgetown University as lead sponsor. 1 are open to participants now and 4 have results posted.

Phase 1 2Phase 2 5Phase 3 3No phase 4(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Durvalumab and Tremelimumab in Combination With Chemotherapy in HIV-infected Patients With Non-small Cell Lung CancerRecruitingNCT04499053Phase 2
• Nivolumab and 177Lu-DOTA0-Tyr3-Octreotate for Patients With Extensive-Stage Small Cell Lung CancerCompletedNCT03325816Phase 1/2Results posted
• A Phase I/II Study of Ganetespib in Combination With DoxorubicinTerminatedNCT02261805Phase 1/2Results posted
• Reader Study of DeltaView™ Chest Radiograph SoftwareCompletedNCT01261507Results posted
• Testing of Computer Aided Detection Software for Riverain Medical GroupCompletedNCT00906789Results posted
• Educating Providers About Lung ScreeningCompletedNCT05064046Not applicable
• Educating QUitline Callers About Lung Cancer ScreeningCompletedNCT05046951Phase 3
• Tiragolumab With Atezolizumab Plus Bevacizumab in Previously-Treated Advanced Non-squamous NSCLCActive, not recruitingNCT04958811Phase 2
• A Patient and Provider Intervention to Address Health Disparities in Lung Cancer ScreeningActive, not recruitingNCT04675476Not applicable
• The Lung Screening, Tobacco and Health ProjectCompletedNCT03200236Phase 3
• Lombardi Comprehensive Cancer Center/Legacy Pilot Study to Reduce Adverse Smoking Outcomes in the Context of Lung Cancer ScreeningCompletedNCT02267096Phase 3
• Vaccine Therapy, Interleukin-2, and Sargramostim in Treating Patients With Advanced TumorsCompletedNCT00003125Phase 2